Welcome to the Recombinant Antibody Network

The Recombinant Antibody Network is a consortium of highly integrated technology centers at UCSF, the University of Chicago, and the University of Toronto, unified under a common goal to generate therapeutic grade recombinant antibodies at a proteome wide scale for biology and biomedicine.

Given that over half the human proteome is not annotated and that functional antibodies are not reliably available, a complete set of validated antibodies would greatly advance all areas of biology, including cancer therapy and infectious disease control. To undertake these challenges, RAN is systematically and comprehensively profiling families of protein targets using novel, modern high-throughput in vitro technology.

Latest Publications

Structural Survey of Antigen Recognition by Synthetic Human Antibodies

Gorelik M; Miersch S; Sidhu S S

Structural Survey of Antigen Recognition by Synthetic Human Antibodies Journal Article

In: Cold Spring Harb Protoc, vol. 2025, no. 2, pp. pdb.over107759, 2025, ISSN: 1559-6095.

Abstract | Links

Engineered protein G variants for multifunctional antibody-based assemblies

Slezak T; O'Leary K M; Li J; Rohaim A; Davydova E K; Kossiakoff A A

Engineered protein G variants for multifunctional antibody-based assemblies Journal Article

In: Protein Sci, vol. 34, no. 2, pp. e70019, 2025, ISSN: 1469-896X.

Abstract | Links

Structural insights into translocation and tailored synthesis of hyaluronan

Górniak I; Stephens Z; Erramilli S K; Gawda T; Kossiakoff A A; Zimmer J

Structural insights into translocation and tailored synthesis of hyaluronan Journal Article

In: Nat Struct Mol Biol, vol. 32, no. 1, pp. 161–171, 2025, ISSN: 1545-9985.

Abstract | Links

Latest News

Scroll to Top